Linkage of Fibroblast Growth Factor 23 and Phosphate in Serum: Phosphate and Fibroblast Growth Factor 23 Reduction by Increasing Dose of Sevelamer
Amir Ghorbanihaghjo, Hassan Argani, Zahra Golmohamadi, Nadereh Rashtchizadeh, Mehran Mesgari Abbasi, Nasrin Bargahi, Amir Mansour Vatankhah, Davoud Sanajou
J Bone Metab. 2018;25(3):153-159.   Published online 2018 Aug 31     DOI: https://doi.org/10.11005/jbm.2018.25.3.153
Citations to this article as recorded by Crossref logo
Vascular Calcification and the Gut and Blood Microbiome in Chronic Kidney Disease Patients on Peritoneal Dialysis: A Pilot Study
Ana Merino-Ribas, Ricardo Araujo, Luciano Pereira, Joana Campos, Luísa Barreiros, Marcela A. Segundo, Nádia Silva, Carolina F. F. A. Costa, Janete Quelhas-Santos, Fábio Trindade, Inês Falcão-Pires, Ines Alencastre, Ioana Bancu Dumitrescu, Benedita Sampaio
Biomolecules.2022; 12(7): 867.     CrossRef
An update on vascular calcification and potential therapeutics
Anubha Singh, Simran Tandon, Chanderdeep Tandon
Molecular Biology Reports.2021; 48(1): 887.     CrossRef
Longitudinal change in c-terminal fibroblast growth factor 23 and outcomes in patients with advanced chronic kidney disease
Helen V. Alderson, Rajkumar Chinnadurai, Sara T. Ibrahim, Ozgur Asar, James P. Ritchie, Rachel Middleton, Anders Larsson, Peter J. Diggle, Tobias E. Larsson, Philip A. Kalra
BMC Nephrology.2021;[Epub]     CrossRef
Fibroblast Growth Factor-23-Klotho Axis in Cardiorenal Syndrome: Mediators and Potential Therapeutic Targets
José Alberto Navarro-García, Laura González-Lafuente, María Fernández-Velasco, Luis M. Ruilope, Gema Ruiz-Hurtado
Frontiers in Physiology.2021;[Epub]     CrossRef